Loading…
Loading…
BINP (Bionoid Pharma, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
NEW YORK CITY, NEW YORK / ACCESS Newswire / August 12, 2025 / AI Maverick Intel Inc. (OTCID:BINP), a technology-driven innovator focused on redefining how businesses acquire and engage customers through artificial intelligence, today provided a corporate update. On July 30, 2025, the Company announced its selection of IBN, a leading multi-channel financial news and publishing platform serving both private and public companies, to direct AI Maverick Intel's corporate communications.
NEW YORK CITY, NEW YORK / ACCESS Newswire / July 30, 2025 / AI Maverick Intel Inc. (OTC:BINP), a technology-forward company focused on transforming how businesses acquire and engage customers through artificial intelligence, has selected IBN, a multifaceted financial news and publishing company serving private and public entities, to spearhead its corporate communications efforts. AI Maverick Intel delivers human-like, AI-powered prospecting through its proprietary platform, enabling intelligent engagement across sectors including healthcare, biotech, insurance, and transportation.
NEW YORK CITY, NEW YORK / ACCESS Newswire / July 17, 2025 / AI Maverick Intel, Inc. (OTCID:BINP) ("AI Maverick" or the "Company") today announces the full rollout of its next-generation prospecting engine-enabling revenue teams to research, engage, and qualify prospects at scale without the need for additional headcount. Key Capabilities Comprehensive contact intelligence - Millions of structured and unstructured data points are aggregated into unified profiles, surfacing job changes, buying signals, and personal preferences in real time.
Company Has Initiated FINRA Process to Complete Rebranding and Ticker Update NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bionoid Pharma, Inc. (OTC PINK:BINP) ("Bionoid" or the "Company") is pleased to confirm that, following the previously announced rebranding initiative, the State of Delaware has approved the Company's formal name change to AI Maverick Intel, Inc., effective April 30, 2025. The Company has submitted the necessary filings with FINRA to update its name and trading symbol on the OTC Markets.
NEW YORK CITY, NEW YORK / ACCESS Newswire / May 16, 2025 / Bionoid Pharma Inc. (OTC PINK:BINP) proudly announces its corporate rebranding to AI Maverick Intel, Inc., marking a significant transformation in its strategic direction. This change underscores the company's commitment to leveraging advanced artificial intelligence technologies to revolutionize customer acquisition and engagement across healthcare, biotech, and other sectors.
NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its audited financial statements for the fiscal year ended December 31, 2024. The audit was conducted by Aloba Awomolo & Partners LLP, Chartered Professional Accountants, who were engaged earlier this year as Bionoid's external auditor.
NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced it has engaged Aloba, Awomolo & Partners, a PCAOB-registered accounting firm, as its independent external auditor for the fiscal year ended December 31, 2024. This engagement underscores Bionoid's commitment to robust financial governance and transparency, aligning with its strategic initiatives to enhance market presence and shareholder value.
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced that it has submitted an application to uplist from the OTC Pink to the OTCQB Venture Market. The application process involves a thorough review by OTC Markets Group, which assesses the company's financials, governance, and disclosures.
No recent filings indexed.